Stem cell treatment for damaged eye blood vessels in diabetes
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests human iPSC–derived (lab-grown) cells aimed at repairing fragile, damaged blood vessels in diabetic retinopathy. It also involves eye exams and a small skin biopsy to support the research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 21 to 98
- You have diabetes (or you are a healthy age-matched control)
- You can cooperate with the eye exam schedule
- You agree to a small skin punch biopsy
- You do not currently have a serious infection (HIV, hepatitis B or C, or tuberculosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study looks at eye tissue from people with advanced diabetic retinopathy to understand why the disease gets so severe. It aims to find new ways to treat or prevent blindness in the future. You would be contributing tissue from a surgery you're already having.
This study tests a new treatment that uses your own stem cells to create retinal cells, which are then placed in your eye. The goal is to see if this can help improve vision for people with advanced age-related macular degeneration.
This Phase 1 study tests an experimental transplant made from your own cells to try to improve vision in people with advanced “late dry” age-related macular degeneration (AMD). It focuses first on safety, and may help some participants with limited central vision.
This study looks at stem-cell treatment to help vision in adults whose retina or optic nerve damage is not expected to improve on its own. You may be a candidate if your eye exam shows documented, stable or slowly changing damage and you can safely complete follow-up eye visits.
Hear when a new Diabetes Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.